Histological categorisation of fibrotic cancer stroma in advanced rectal cancer

Gut

Volumn 53, Issue 4, 2004, Pages 581-586

  Ueno, H ^a   Jones, A M ^b   Wilkinson, K H ^c   Jass, J R ^d   Talbot, I C ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Cancer Research   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOFIBROBLAST; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; T LYMPHOCYTE; TUMOR CELL;

ADENOCARCINOMA; FIBROBLASTS; FIBROSIS; HUMANS; LYMPHOCYTE COUNT; MULTIVARIATE ANALYSIS; PROGNOSIS; RECTAL NEOPLASMS; STROMAL CELLS; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS;

EID: 1642297480     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.028365     Document Type: Article

References (30)

1. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-49.
2. Barsky SH, Gopalakrishna R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 Mice. Cancer Res 1987;47:1663-7.
3. Nakanishi H, Oguri K, Takenaga K, et al. Differential fibrotic stromal response of host tissue to low-and high-metastatic cloned lewis lung carcinoma cells. Lab Invest 1994;70:324-32.
4. Halvorsen TB, Seim EVA. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989;42:162-6.
5. Schürch W, Lagacé R, Seemayer TA. Myofibroblastic stromal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet 1982;154:351-8.
6. Shimosato Y, Hashimoto T, Kodama T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancer. Am J Surg Pathol 1980;4:365-73.
7. Kajiyama K, Maeda T, Takenaka K, et al. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma. A special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. Am J Surg Pathol 1999;23:892-902.
8. Breuninger H, Schaumburg-Lever G, Holzshuh J, et al. Desmoplastic squamous cell carcinoma of skin and vermilion surface. A highly malignant subtype of skin cancer. Cancer 1996;79:915-19.
9. Dvorak HF. Tumors: wounds that do not heal; similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
10. Ueno H, Jones A, Jass JR, et al. Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in advanced rectal cancer. Histopathology 2002;40:327-34.
11. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-32.
12. Ueno H, Mochizuki H, Shinto E, et al. Histological indices in biopsy specimens for estimating the probability of extended local spread in rectal cancer. Cancer 2002;94:2882-91.
13. Iozzo RV. Editorial: Tumor stroma as a regulator of neoplastic behavior. Lab Invest 1995;73:157-60.
14. Gabbert H, Wagner R, Moll R, et al. Tumour dedifferenatiation: an important step in tumour invasion. Clin Exp Metast 1985;3:257-79.
15. Hewitt RE, Powe DG, Carter GI, et al. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 1993;53:62-9.
16. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-35.
17. Ueno H, Mochizuki H, Hatsuse K, et al. Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000;231:59-66.
18. Speirs V, Ray KP, Freshney RI. Paracrine control of differentiation in the alveolar carcinoma, A549, by human faetal lung fibroblasts. Br J Cancer 1991;64:693-9.
19. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinse gene specifically expressed in stromal cells of breast carcinoma. Nature 1990;348:699-704.
20. Gleave M, Hsieh JT, Gao C, et al. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991;51:3753-61.
21. Lieubeau B, Garrigue L, Barbieux I, et al. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 1994;54:6526-32.
22. Stoker M, Gherardi E, Perryman M, et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987;327:239-42.
23. Shürlch W, Seemazer TA, Gabbiani G. Myofibroblast. In: Sternberg S, ed. Histology for pathologists, 2nd edn. Philadelphia: Lippincott-Raven Publishers, 1997:129-65.
24. Ohtoni H, Nagai T, Nagura H. Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: comparison with granulation tissue reaction. Jpn J Cancer Res 1995;86:833-9.
25. Martin M, Pujuguet P, Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 1996;192:712-17.
26. Black MM, Speer FD, Opler SR. Structural representations of tumor-host relations in mammary carcinoma. Biologic and prognostic significance. Am J Clin Pathol 1956;26:250-65.
27. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: histological perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
28. Ueno H, Mochizuki H, Hase K, et al. A study on the clinical significance of lymphatic tissue responses against rectal cancer. J Jpn Soc Coloproctol 1994;47:430-41.
29. Lieubeau B, Heymann MF, Henry F, et al. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 1999;81:629-36.
30. Dvorak HF, Dvorak AM, Manseau EJ, et al. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage and infarction in line 1 tumor regression. J Nat Cancer Inst 1979;62:1459-73.